I get the very strong impression that the 220 will be the go to ETD for air cargo. The main reason for that is TSA approval and a statement that I think the VP of Marketing made in a CC around 6 months ago stating that Implant's focus was to move into areas that did not compete with other companies. He obviously meant air cargo and the 220 and Morpho and Smith's.
1. It's technology is next generation. Details? Is it just much faster clear down?
2. Implant has patents namely #13 which will make it difficult for others to compete in air cargo ETD down the road - 1-2 years. This by way of adding the mass spectrometer to the tail end to greatly increase sensitivity and lower false positives. Implant's position here is so strong that no other company will be working in this area for some time.
3. Implant has patents on vortex and particle trace collection which will eventually allow creating very high throughput ETD. They could also automate swabbing.
It is interesting how little information we as investors have on technical details. I guess the nature of this business is to keep certain details nebulous. It is nice to know that the ETD business has so much room to expand into.